Image de couverture de livre

Editorial: Right‐Sizing Colonoscopy Referrals for Patients With Possible Signs and Symptoms of Colorectal Cancer

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Nicole P. Mirabadi, Samir Gupta
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Alimentary Pharmacology & Therapeutics
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Research Communication: Effects of Screening Colonoscopy on Colorectal Cancer Mortality: Lessons From Comparative Analyses of Randomised Trials
par: Hermann Brenner, et autres
Publié: (2025)

Editorial: Good Vibrations for Better Colonoscopy Preparation and Constipation
par: Benjamin Kalivas, et autres
Publié: (2025)

Editorial: When and What to Ask—Capturing the Symptoms Experienced by Patients With PSC
par: Christopher L. Bowlus, et autres
Publié: (2025)

Editorial: ‘Risk‐Adapted Starting Ages of Colorectal Cancer Screening for People With Diabetes or Metabolic Syndrome’
par: James Turvill
Publié: (2025)

Editorial: When and What to Ask—Capturing the Symptoms Experienced by Patients With PSC. Authors' Reply
par: Natassia Tan, et autres
Publié: (2025)

Editorial: ‘Risk‐Adapted Starting Ages of Colorectal Cancer Screening for People With Diabetes or Metabolic Syndrome’. Authors' Reply
par: Hermann Brenner, et autres
Publié: (2025)

Editorial: Surveillance Colonoscopy for Detection of Neoplasia in Inflammatory Bowel Disease—Is Dye‐Based Chromoendoscopy Always the Final Answer?
par: Andrea Cassinotti, et autres
Publié: (2025)

Letter: Balancing Cost and Consequence of Colon Capsule Endoscopy in Colorectal Cancer Pathways—Finding the Sweet Spot
par: Ian Io Lei, et autres
Publié: (2025)

Editorial: High‐Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer
par: Alexandra Hickey, et autres
Publié: (2025)

Editorial: HBV Integration: A Possible Key Driver in the Course of Patients With Chronic HBV Infection Under Viral Suppression
par: Hidenori Toyoda
Publié: (2025)

Editorial: High‐Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer—Authors' Reply
par: Monica E. W. Derks, et autres
Publié: (2025)

Letter: Enhancing Risk‐Adapted Colorectal Cancer Screening for People With Diabetes—Authors' Reply
par: Teresa Seum, et autres
Publié: (2025)

Letter: FIT ‐Based Triage for Symptomatic Colonoscopy‐Diagnostic Yield Is Not the Same as Pathway Safety
par: Stjepan Škudar
Publié: (2026)

Editorial: HBV Integration—A Possible Key Driver on the Course of Patients With Chronic HBV Infection Under Viral Suppression. Authors' Reply
par: Qin Ning, et autres
Publié: (2025)

Diagnostic Accuracy of an Add‐On, Blood‐Based Screening Test for Colorectal Cancer in Two Established Screening Programmes
par: Tim L. Kortlever, et autres
Publié: (2025)

Letter: Methodological Gaps Undermine Conclusions on Electronic Nose Use for Colorectal Cancer Detection—Authors' Reply
par: Milou. L. M. van Riswijk, et autres
Publié: (2025)

Real‐World Performance of FIT Triage for Symptomatic Colonoscopy: Analysis of the UK National Endoscopy Database ( NED )
par: David Beaton, et autres
Publié: (2026)

Prevalence and Predictors of Symptoms of Anxiety or Depression at Diagnosis in Patients With Inflammatory Bowel Disease: An Inception Cohort
par: Christy Riggott, et autres
Publié: (2025)

Novel Symptom Subgroups in Patients With Irritable Bowel Syndrome Are Associated With Healthcare Utilisation in Secondary and Tertiary Care
par: Vivek C. Goodoory, et autres
Publié: (2026)

Primary Sclerosing Cholangitis in the Absence of Inflammatory Bowel Disease Increases the Risk of Colorectal Cancer: A Multi‐Centre Propensity Score Matched Analysis
par: Saqr Alsakarneh, et autres
Publié: (2025)

Editorial: Navigating the Beta‐Blocker Dilemma in Advanced Liver Cirrhosis—When Is the Right Time to Discontinue?
par: Louise J. M. Alferink, et autres
Publié: (2024)

Editorial: Peroxisome Proliferator‐Activated Receptor Agonists—Shifting the Goalpost From Biochemical Response to Symptom Directed Therapy in PBC
par: Henry H. Nguyen, et autres
Publié: (2026)

Burden of Invasive Fungal Diseases in Patients With Alcohol‐Related Hepatitis and Organ Failure
par: Charlotte Mouliade, et autres
Publié: (2025)

Editorial: Optimal Treatment for Older Patients With Inflammatory Bowel Disease: How to Detect and Manage Frailty? Authors' Reply
par: A. B. Fons, et autres
Publié: (2026)

Editorial: Navigating the Beta‐Blocker Dilemma in Advanced Liver Cirrhosis—When Is the Right Time to Discontinue? Authors' Reply
par: Ting Wang, et autres
Publié: (2024)

Editorial: Predicting Hepatocellular Cancer in Clinical Practice. Authors' Reply
par: Shuaibing Ying, et autres
Publié: (2026)

Persistence of Symptoms of Anxiety and Depression in Inflammatory Bowel Disease: A Longitudinal Follow‐Up Study
par: Christy Riggott, et autres
Publié: (2025)

Systematic Review: The Relationship Between the Faecal Microbiome and Colorectal Neoplasia in Shotgun Metagenomic Studies
par: Sarah Manning, et autres
Publié: (2025)

Editorial: Is TIPSS Implantation Effective in Patients With Portal Hypertensive Gastropathy?
par: Marlene Reincke, et autres
Publié: (2024)

Faecal Volatile Organic Compounds to Detect Colorectal Neoplasia in Lynch Syndrome—A Prospective Longitudinal Multicentre Study
par: Elsa L. S. A. van Liere, et autres
Publié: (2024)

Editorial: Immune Checkpoint Inhibitors and HBV Reactivation in Liver Cancer—Reassurance With Vigilance
par: Romeo Kuo‐Cheng Wu, et autres
Publié: (2025)

Editorial: Updated COVID‐19 Boosters—Tailoring Protection for Patients With IBD
par: James L. Alexander, et autres
Publié: (2024)

Editorial: Addressing Unmet Needs and Socioeconomic Disparity in Patients With Autoimmune Hepatitis
par: Seren Gedallovich, et autres
Publié: (2024)

Editorial: Linking Patients With Cirrhosis to Clinical Care—The Hurdles and Way Forward
par: Jimmy Che‐To Lai, et autres
Publié: (2026)

Outcome After Surgery for Colon Cancer in a National Cohort of Patients With and Without Inflammatory Bowel Disease
par: Erik Lundqvist, et autres
Publié: (2025)

Editorial: Polypharmacy in MASLD—An Overlooked Epidemic Disproportionately Affecting Women and Patients With Cirrhosis
par: Mary Yue Wang, et autres
Publié: (2025)

Editorial: Assessing the Prognosis of Patients With HBV and ACLF—Comorbidities Matter. Authors' Reply
par: Jiong Yu, et autres
Publié: (2024)

Review Article: Individualised Management of Reflux‐Like Symptoms—Strategies Beyond Acid Suppression
par: Peter J. Kahrilas, et autres
Publié: (2025)

Correction to ‘Risk of Hepatocellular Cancer in U.S. Patients With Compensated Cirrhosis Treated With Direct‐Acting Antivirals Versus Interferon’
Publié: (2025)

Editorial: MetALD and Risk of Gastrointestinal Cancer—What Can We Learn From Japan?
par: Hannes Hagström, et autres
Publié: (2025)